All Stories

  1. Two phases of T cell reactivity after COVID-19
  2. ADAR-induced mutations in SARS-CoV-2- RNA
  3. Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
  4. Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML